ArticleBlood advances2023

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort.

Jackson T Bowers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.